American Financial Group’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

American Financial Group’s Portfolio ELOX Stock Details ELOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-37,000	Closed	-$178K	–	85
2023 Q3	$178K	Hold	37,000	–	–	0.06%	77
2023 Q2	$144K	Hold	37,000	–	–	0.04%	88
2023 Q1	$93K	Hold	37,000	–	–	0.03%	89
2022 Q4	$67K	Hold	37,000	–	–	0.02%	92
2022 Q3	$252K	Hold	37,000	–	–	0.09%	83
2022 Q2	$400K	Hold	37,000	–	–	0.13%	74
2022 Q1	$829K	Hold	37,000	–	–	0.25%	56
2021 Q4	$1.04M	Hold	37,000	–	–	0.29%	54
2021 Q3	$2.41M	Hold	37,000	–	–	0.64%	41
2021 Q2	$2.94M	Buy	+37,000	New	+$3.09M	0.75%	39

Other funds holding ELOX

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

American Financial Group's ELOX Position: Q4 2023 in Review

American Financial Group sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2023, closing a stake of 37,000 shares — an estimated $178K sold.

American Financial Group first reported a position in ELOX in Q2 2021 and held it in 10 quarters. The position peaked at $2.94M in Q2 2021. 4 funds tracked by Wall St. Rank hold ELOX as of Q4 2023.

American Financial Group reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
American Financial Group sold 37,000 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $178K.
American Financial Group first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
American Financial Group's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $2.94M in Q2 2021.
4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on American Financial Group's 13F filing for Q4 2023, filed 12 Feb 2024.